LYB001

From Wikipedia, the free encyclopedia

LYB001 is a COVID-19 vaccine candidate developed by Yantai Patronus Biotech Co., Ltd.[1][2][3][4]

It was found to be safe and well tolerated.[5]

Related Articles

Wikiwand AI